Instituto Portugues de Oncologia do Porto Francisco Gentil /ID# 275851

Porto 4200-072

1 studies enrolling now · 1 studies all time

What they study most

Multiple Myeloma

Studies at this site

• A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM) — Recruiting now